Amgen Inc. (VIE:AMGN)

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of EUR 156.09 billion. The enterprise value is 194.95 billion.

Market Cap	156.09B
Enterprise Value	194.95B

Important Dates

The last earnings date was Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	Aug 22, 2025

Share Statistics

Current Share Class	538.48M
Shares Outstanding	n/a
Shares Change (YoY)	+0.28%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	80.92%
Float	537.12M

Valuation Ratios

The trailing PE ratio is 26.14 and the forward PE ratio is 16.22.

PE Ratio	26.14
Forward PE	16.22
PS Ratio	5.09
PB Ratio	19.04
P/TBV Ratio	n/a
P/FCF Ratio	15.87
P/OCF Ratio	13.95
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.57, with an EV/FCF ratio of 19.82.

EV / Earnings	32.65
EV / Sales	6.30
EV / EBITDA	13.57
EV / EBIT	20.29
EV / FCF	19.82

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 5.67.

Current Ratio	1.28
Quick Ratio	0.82
Debt / Equity	5.67
Debt / EBITDA	3.27
Debt / FCF	4.73
Interest Coverage	3.32

Financial Efficiency

Return on equity (ROE) is 81.71% and return on invested capital (ROIC) is 10.56%.

Return on Equity (ROE)	81.71%
Return on Assets (ROA)	7.71%
Return on Invested Capital (ROIC)	10.56%
Return on Capital Employed (ROCE)	16.33%
Revenue Per Employee	1.09M
Profits Per Employee	213,227
Employee Count	28,000
Asset Turnover	0.40
Inventory Turnover	1.57

Taxes

In the past 12 months, Amgen has paid 1.06 billion in taxes.

Income Tax	1.06B
Effective Tax Rate	15.03%

Stock Price Statistics

The stock price has increased by +1.24% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+1.24%
50-Day Moving Average	253.00
200-Day Moving Average	259.17
Relative Strength Index (RSI)	74.55
Average Volume (20 Days)	93

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.59

Income Statement

In the last 12 months, Amgen had revenue of EUR 30.66 billion and earned 5.97 billion in profits. Earnings per share was 11.02.

Revenue	30.66B
Gross Profit	21.48B
Operating Income	9.51B
Pretax Income	7.03B
Net Income	5.97B
EBITDA	14.05B
EBIT	9.51B
Earnings Per Share (EPS)	11.02

Balance Sheet

The company has 8.05 billion in cash and 46.52 billion in debt, giving a net cash position of -38.47 billion.

Cash & Cash Equivalents	8.05B
Total Debt	46.52B
Net Cash	-38.47B
Net Cash Per Share	n/a
Equity (Book Value)	8.20B
Book Value Per Share	15.22
Working Capital	5.19B

Cash Flow

In the last 12 months, operating cash flow was 11.19 billion and capital expenditures -1.35 billion, giving a free cash flow of 9.83 billion.

Operating Cash Flow	11.19B
Capital Expenditures	-1.35B
Free Cash Flow	9.83B
FCF Per Share	n/a

Margins

Gross margin is 70.05%, with operating and profit margins of 31.02% and 19.47%.

Gross Margin	70.05%
Operating Margin	31.02%
Pretax Margin	22.92%
Profit Margin	19.47%
EBITDA Margin	45.82%
EBIT Margin	31.02%
FCF Margin	32.08%

Dividends & Yields

This stock pays an annual dividend of 8.59, which amounts to a dividend yield of 2.96%.

Dividend Per Share	8.59
Dividend Yield	2.96%
Dividend Growth (YoY)	5.04%
Years of Dividend Growth	8
Payout Ratio	72.03%
Buyback Yield	-0.28%
Shareholder Yield	2.68%
Earnings Yield	3.83%
FCF Yield	6.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.69 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.69
Piotroski F-Score	7